1 asset in Nephropathic Cystinosis
Therapeutic assets addressing Nephropathic Cystinosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
dft383 Nephropathic Cystinosis | Novartis Pharmaceuticals | P1/2 | NR () |
Therapeutic assets addressing Nephropathic Cystinosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
dft383 Nephropathic Cystinosis | Novartis Pharmaceuticals | P1/2 | NR () |